[Neuroprotection in neurocritical care].

Neuroprotektion in der Neurointensivmedizin.
Hypothermia, induced Intracranial pressure Resuscitation Stroke Subarachnoid hemorrhage

Journal

Medizinische Klinik, Intensivmedizin und Notfallmedizin
ISSN: 2193-6226
Titre abrégé: Med Klin Intensivmed Notfmed
Pays: Germany
ID NLM: 101575086

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 25 06 2019
accepted: 16 07 2019
revised: 16 07 2019
pubmed: 30 8 2019
medline: 23 10 2019
entrez: 30 8 2019
Statut: ppublish

Résumé

In intensive care medicine neuroprotection is understood mostly as various measures to avoid secondary brain damage after initial trauma, as in stroke, intracranial hemorrhage and resuscitation. Every brain trauma differs in the damage pattern and dynamics depending on the primary form of injury. Therefore, there are targeted treatment approaches depending on the pathophysiology of the medical condition. In addition, neuroprotective methods are desirable that are effective in the majority of patients with acute brain injury. In actual fact, in all forms of acute brain injury certain pathophysiological courses are encountered, which can lead to secondary brain damage depending on the intensity, e.g. reperfusion injury, damage to the blood-brain barrier and excitotoxicity. There is evidence to suggest that the creation of physiologically normal conditions leads to a favorable situation for the damaged brain. This article firstly describes the relevance of neuroprotective measures in neurocritical care medicine. Subsequently, general pathophysiological mechanisms in brain trauma are described. Following this, the pathophysiology and treatment options in brain pressure crises (reduction of intracranial pressure), anemia (transfusion management), hyperglycemia and hypoglycemia (adjustment of the blood sugar level) are dealt with. Finally, the use and benefits of therapeutic hypothermia are discussed. This has a special position as the only clinically effective individual measure for neuroprotection. The focus here is on the application following circulatory and cardiac arrest and resuscitation.

Identifiants

pubmed: 31463676
doi: 10.1007/s00063-019-00608-8
pii: 10.1007/s00063-019-00608-8
doi:

Types de publication

Journal Article Review

Langues

ger

Sous-ensembles de citation

IM

Pagination

635-641

Références

Continuum (Minneap Minn). 2018 Dec;24(6):1588-1602
pubmed: 30516597
Lancet Glob Health. 2013 Nov;1(5):e239-40
pubmed: 25104481
N Engl J Med. 2013 Dec 5;369(23):2197-206
pubmed: 24237006
Anesthesiology. 2002 Oct;97(4):868-74
pubmed: 12357152
N Engl J Med. 2001 Nov 8;345(19):1359-67
pubmed: 11794168
Intensive Care Med. 2009 Oct;35(10):1738-48
pubmed: 19636533
Stroke. 2016 Dec;47(12):2888-2895
pubmed: 27834742
Br J Haematol. 2013 Feb;160(4):445-64
pubmed: 23278459
N Engl J Med. 2006 Feb 2;354(5):449-61
pubmed: 16452557
Crit Care. 2012 Oct 22;16(5):R203
pubmed: 23082798
Crit Care Med. 2008 Dec;36(12):3233-8
pubmed: 18936695
Curr Opin Crit Care. 2013 Apr;19(2):83-91
pubmed: 23385374
Neurosurg Clin N Am. 2010 Apr;21(2):221-33
pubmed: 20380965
Crit Care. 2009;13(3):R89
pubmed: 19519893
Crit Care Med. 2007 Oct;35(10):2383-9
pubmed: 17717494
N Engl J Med. 2009 Mar 26;360(13):1283-97
pubmed: 19318384
Best Pract Res Clin Anaesthesiol. 2010 Dec;24(4):495-509
pubmed: 21619862
J Clin Neurosci. 2016 Feb;24:22-7
pubmed: 26461911
N Engl J Med. 2002 Feb 21;346(8):549-56
pubmed: 11856793
Stroke. 2018 Mar;49(3):e46-e110
pubmed: 29367334
Nat Rev Neurol. 2013 Apr;9(4):231-6
pubmed: 23443846
Resuscitation. 2015 Oct;95:1-80
pubmed: 26477410
J Neurotrauma. 2000 Jun-Jul;17(6-7):493-5
pubmed: 10937891
Crit Care Med. 2006 Mar;34(3):617-23; quiz 624
pubmed: 16521258
Crit Care Clin. 2014 Oct;30(4):765-83
pubmed: 25257740
JAMA. 2018 Dec 4;320(21):2211-2220
pubmed: 30357266
Crit Care. 2008;12(4):R98
pubmed: 18680584

Auteurs

Rainer Kollmar (R)

Klinik für Neurologie und Neurointensivmedizin, Klinikum Darmstadt, Grafenstr. 9, 64283, Darmstadt, Deutschland. rainer.kollmar@mail.klinikum-darmstadt.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH